This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Insurers Keep Ear on Supreme Court

NEW YORK ( TheStreet) -- Health insurers will be paying close attention when the Supreme Court convenes Wednesday to once again tackle issues related to Obamacare.

The court won't issue a formal decision until June , but traders will try to decipher which way the wind is blowing from the justices' questions.

"I think the stocks have been up and down a bit as people tried to infer something from the oral arguments," said Matthew Coffina, senior health care analyst at Morningstar. "Today [Tuesday] the stocks started out sort of down just 1% or 2%, because, again, it's hard to infer much from the questions the justices are asking."

Wednesday brings the discussion of "severability" to the fore as the justices will have to determine if the individual mandate, if struck down as unconstitutional, can be separated from the rest of the Obamacare legislation.

Part of the deal health care companies like UnitedHealth Group (UNH - Get Report), Aetna (AET - Get Report) and Cigna (CI - Get Report) have to comply with under the Patient Protection and Affordable Care Act, otherwise known as Obamacare, is to provide care without regard to pre-existing conditions.

The Supreme Court heard oral arguments Tuesday on the individual mandate provision of the Patient Protection and Affordable Care Act and early reports pointed to reservations that the justices could lean in opposition to the legislation.

"I think it is true that if most questions in life are matters of degree ... the young person who is uninsured is uniquely proximately very close to affecting the rates of insurance and the costs of providing medical care in a way that is not true in other industries," Justice Anthony Kennedy, considered a swing vote on the bench, said in the oral arguments.

If the Supreme Court ultimately decides in June to strike down the individual mandate and uphold the pre-existing conditions stipulation, it would likely create an unfriendly scenario for the health care industry as they'd have to provide care for people that didn't qualify before the Affordable Care Act.

"The issue of severability is ultimately an issue of what Congress intended," said Greg Magarian, a law professor at Washington University in St. Louis who clerked for former Associate Justice John Paul Stevens.

The best scenario for health care stocks, said Morningstar's Coffina, is that the justices uphold the law entirely; at worst, the whole law falls. But Coffina said the companies will remain healthy, regardless.

"It's not necessarily a main driver of results for these companies," he said.

-- Written by Joe Deaux in New York.

>Contact by Email.

>Follow Joe Deaux on Twitter. Subscribe on Facebook.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AET $114.41 0.49%
CI $137.90 -0.27%
UNH $132.56 0.35%
AAPL $95.43 1.90%
FB $117.95 -0.52%


Chart of I:DJI
DOW 17,780.25 -110.91 -0.62%
S&P 500 2,065.22 -16.21 -0.78%
NASDAQ 4,778.7780 -38.8160 -0.81%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs